75 related articles for article (PubMed ID: 11258416)
1. CD28 and T cell co-stimulation.
Holdorf AD; Kanagawa O; Shaw AS
Rev Immunogenet; 2000; 2(2):175-84. PubMed ID: 11258416
[TBL] [Abstract][Full Text] [Related]
2. NF-κB family of transcription factors: biochemical players of CD28 co-stimulation.
Tuosto L
Immunol Lett; 2011 Mar; 135(1-2):1-9. PubMed ID: 20863851
[TBL] [Abstract][Full Text] [Related]
3. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
[TBL] [Abstract][Full Text] [Related]
4. CD28-mediated co-stimulation: a quantitative support for TCR signalling.
Acuto O; Michel F
Nat Rev Immunol; 2003 Dec; 3(12):939-51. PubMed ID: 14647476
[No Abstract] [Full Text] [Related]
5. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
[TBL] [Abstract][Full Text] [Related]
6. Emerging paradigms of T-cell co-stimulation.
Kroczek RA; Mages HW; Hutloff A
Curr Opin Immunol; 2004 Jun; 16(3):321-7. PubMed ID: 15134781
[TBL] [Abstract][Full Text] [Related]
7. Targeting lymphocyte co-stimulation: from bench to bedside.
Felix NJ; Suri A; Salter-Cid L; Nadler SG; Gujrathi S; Corbo M; Aranda R
Autoimmunity; 2010 Nov; 43(7):514-25. PubMed ID: 20429850
[TBL] [Abstract][Full Text] [Related]
8. CD28 T cell costimulatory receptor function is negatively regulated by N-linked carbohydrates.
Ma BY; Mikolajczak SA; Yoshida T; Yoshida R; Kelvin DJ; Ochi A
Biochem Biophys Res Commun; 2004 Apr; 317(1):60-7. PubMed ID: 15047148
[TBL] [Abstract][Full Text] [Related]
9. CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism.
Collette Y; Razanajaona D; Ghiotto M; Olive D
Eur J Immunol; 1997 Dec; 27(12):3283-9. PubMed ID: 9464816
[TBL] [Abstract][Full Text] [Related]
10. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
Watson CL; Furlong SJ; Hoskin DW
Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
[TBL] [Abstract][Full Text] [Related]
11. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
12. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
13. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
14. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
15. CD28 in thymocyte development and peripheral T cell activation in mice exposed to suspended particulate matter.
Drela N; Ześko I; Jakubowska M; Biernacka M
Toxicol Appl Pharmacol; 2006 Sep; 215(2):179-88. PubMed ID: 16580703
[TBL] [Abstract][Full Text] [Related]
16. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
Sung JL; Lin JT; Gorham JD
Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
[TBL] [Abstract][Full Text] [Related]
17. Modeling costimulation.
van der Merwe PA
Nat Immunol; 2000 Sep; 1(3):194-5. PubMed ID: 10973274
[No Abstract] [Full Text] [Related]
18. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC
Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884
[TBL] [Abstract][Full Text] [Related]
19. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.
Chen L
Nat Rev Immunol; 2004 May; 4(5):336-47. PubMed ID: 15122199
[No Abstract] [Full Text] [Related]
20. T lymphocyte co-signaling pathways of the B7-CD28 family.
Wang S; Chen L
Cell Mol Immunol; 2004 Feb; 1(1):37-42. PubMed ID: 16212919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
